Advertisement

Inflammation

Resource Center

News
Research Summaries
Resources
FDA Alerts From the Journal
Insights
Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows

FDA Alerts

FDA ALERT
joint pain
FDA ALERT
FDA Approves First Biosimilar to Tocilizumab to Treat Adults, Pediatric Patients With Arthritis
11/15/2023

Jessica Ganga

Jessica Ganga
In late September, the FDA approved the first biosimilar to tocilizumab to treat adult and pediatric patients with various indications of arthritis.
11/15/2023
FDA Roundup
FDA
FDA Roundup
Key FDA Approvals on Novel Treatment Options for Menopausal Hot Flashes, CDI, Opioid Overdoses, and More
06/13/2023
This FDA Roundup includes an at-a-glance look at the latest FDA drug approvals in April and May, including treatment for menopausal hot flashes, Clostridioides difficile infection, suspected opioid...
06/13/2023
Inflammation
Inflammation
FDA Approves First and Only Subcutaneous Option for CIDP
03/16/2018
The US Food and Drug Administration approved the drug after trials showed a lower rate of relapse in chronic inflammatory demyelinating polyneuropathy or withdrawal for any other reason.
03/16/2018
FDA ALERT
fda
FDA ALERT
FDA Approves Interchangeable Biosimilar for Psoriatic Arthritis, Other Inflammatory Conditions
11/08/2015

Anthony Calabro, MA

Anthony Calabro, MA
The FDA approved ustekinumab-auub as an interchangeable biosimilar with ustekinumab for multiple inflammatory diseases.
11/08/2015